LU82419A1 - Pyrido(1,2-a)pyrimidines substituees - Google Patents
Pyrido(1,2-a)pyrimidines substituees Download PDFInfo
- Publication number
- LU82419A1 LU82419A1 LU82419A LU82419A LU82419A1 LU 82419 A1 LU82419 A1 LU 82419A1 LU 82419 A LU82419 A LU 82419A LU 82419 A LU82419 A LU 82419A LU 82419 A1 LU82419 A1 LU 82419A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- pyrido
- oxo
- trans
- pyrimidine
- ethenyl
- Prior art date
Links
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 claims description 175
- -1 2- (N-pyrrolidinyl) -ethyl Chemical group 0.000 claims description 154
- 150000001875 compounds Chemical class 0.000 claims description 124
- 150000003839 salts Chemical class 0.000 claims description 48
- 239000000203 mixture Substances 0.000 claims description 34
- 125000004432 carbon atom Chemical group C* 0.000 claims description 28
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims description 26
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 125000001617 2,3-dimethoxy phenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 16
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 16
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 11
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims description 9
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 9
- 238000005888 cyclopropanation reaction Methods 0.000 claims description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 8
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 7
- 150000001735 carboxylic acids Chemical class 0.000 claims description 7
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 6
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims description 5
- 125000002541 furyl group Chemical group 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 125000004076 pyridyl group Chemical group 0.000 claims description 5
- 125000001544 thienyl group Chemical group 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- CBWYZIHBAWXITJ-ZRDIBKRKSA-N 2-[(e)-2-(2-ethoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC=C1OCC CBWYZIHBAWXITJ-ZRDIBKRKSA-N 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 3
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- WIAKUXSZKOKEBR-CSKARUKUSA-N 2-[(e)-2-(3-methoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC(OC)=C1 WIAKUXSZKOKEBR-CSKARUKUSA-N 0.000 claims description 2
- BVLBHDIWDFLDMC-UXBLZVDNSA-N 3-ethyl-2-[(e)-2-(4-methoxyphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CC)=C1\C=C\C1=CC=C(OC)C=C1 BVLBHDIWDFLDMC-UXBLZVDNSA-N 0.000 claims description 2
- KGBJXKLZZUNXQI-VQHVLOKHSA-N 3-methyl-4-oxo-2-[(e)-2-phenylethenyl]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(C)=C1\C=C\C1=CC=CC=C1 KGBJXKLZZUNXQI-VQHVLOKHSA-N 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- NEQDYZLCEWAVPX-AATRIKPKSA-N 2-[(e)-2-(furan-2-yl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(C)=C1\C=C\C1=CC=CO1 NEQDYZLCEWAVPX-AATRIKPKSA-N 0.000 claims 1
- SXFDLTSWCPNTNA-CSKARUKUSA-N 3-ethyl-2-[(e)-2-(2-methoxyphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CC)=C1\C=C\C1=CC=CC=C1OC SXFDLTSWCPNTNA-CSKARUKUSA-N 0.000 claims 1
- SVTVBNUEUUIJDA-AATRIKPKSA-N 3-methyl-4-oxo-2-[(e)-2-thiophen-2-ylethenyl]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(C)=C1\C=C\C1=CC=CS1 SVTVBNUEUUIJDA-AATRIKPKSA-N 0.000 claims 1
- YVXHRAYXYLVPEG-PKNBQFBNSA-N 4-oxo-2-[(e)-2-phenylethenyl]-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC=C1 YVXHRAYXYLVPEG-PKNBQFBNSA-N 0.000 claims 1
- WZZJIHMWWUMTTN-CMDGGOBGSA-N 6-ethyl-7-oxo-5-[(e)-2-phenylethenyl]-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CC)=C1\C=C\C1=CC=CC=C1 WZZJIHMWWUMTTN-CMDGGOBGSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- 238000002844 melting Methods 0.000 description 173
- 230000008018 melting Effects 0.000 description 172
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 48
- 238000000354 decomposition reaction Methods 0.000 description 48
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- LBMGFLVZIOZDHZ-UHFFFAOYSA-N 4h-pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1C=CN=C2C=CC(C(=O)O)=CN21 LBMGFLVZIOZDHZ-UHFFFAOYSA-N 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 18
- 239000002244 precipitate Substances 0.000 description 17
- 229920002554 vinyl polymer Polymers 0.000 description 17
- 238000003756 stirring Methods 0.000 description 16
- 150000002576 ketones Chemical class 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 13
- 238000000862 absorption spectrum Methods 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000005457 ice water Substances 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 11
- 150000004702 methyl esters Chemical class 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- IXXDBGSSNAQIJA-UHFFFAOYSA-N 4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1=CC(=O)N2C=C(C(=O)O)C=CC2=N1 IXXDBGSSNAQIJA-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- SPHZEUOGHAABOU-UHFFFAOYSA-N O=C1CC(=C)N=C2C=CC(C(=O)O)=CN21 Chemical compound O=C1CC(=C)N=C2C=CC(C(=O)O)=CN21 SPHZEUOGHAABOU-UHFFFAOYSA-N 0.000 description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 125000004494 ethyl ester group Chemical group 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 229910000104 sodium hydride Inorganic materials 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000012312 sodium hydride Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 150000001299 aldehydes Chemical class 0.000 description 5
- 230000003266 anti-allergic effect Effects 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 238000007363 ring formation reaction Methods 0.000 description 5
- 159000000000 sodium salts Chemical class 0.000 description 5
- BPLKQGGAXWRFOE-UHFFFAOYSA-M trimethylsulfoxonium iodide Chemical compound [I-].C[S+](C)(C)=O BPLKQGGAXWRFOE-UHFFFAOYSA-M 0.000 description 5
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- LAAGXYIBSJMFCU-UHFFFAOYSA-N 2-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=NC(C)=CC(=O)N21 LAAGXYIBSJMFCU-UHFFFAOYSA-N 0.000 description 3
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 3
- JJNIBLSMIUWQHQ-UHFFFAOYSA-N 4-oxo-2-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C(CC)C=1N=C2N(C(C=1)=O)C=C(C=C2)C(=O)O JJNIBLSMIUWQHQ-UHFFFAOYSA-N 0.000 description 3
- VFMCUTPRJLZEEW-UHFFFAOYSA-N 4h-pyrido[1,2-a]pyrimidine Chemical class C1=CC=CN2CC=CN=C21 VFMCUTPRJLZEEW-UHFFFAOYSA-N 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 230000036783 anaphylactic response Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 3
- 229920000137 polyphosphoric acid Polymers 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 235000015424 sodium Nutrition 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 125000003944 tolyl group Chemical group 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- NNJFRARRNSPGFB-PKNBQFBNSA-N 2-[(e)-2-(2-methylphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC=C1C NNJFRARRNSPGFB-PKNBQFBNSA-N 0.000 description 2
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 2
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 2
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 2
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 2
- MHGMBZMMKSZOGS-CMDGGOBGSA-N 6-ethyl-5-[(e)-2-(2-methylphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CC)=C1\C=C\C1=CC=CC=C1C MHGMBZMMKSZOGS-CMDGGOBGSA-N 0.000 description 2
- PNWRNPXJVJQYSL-BQYQJAHWSA-N 6-ethyl-5-[(e)-2-(3-methoxyphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CC)=C1\C=C\C1=CC=CC(OC)=C1 PNWRNPXJVJQYSL-BQYQJAHWSA-N 0.000 description 2
- BRJCJAMOXBYZNP-UHFFFAOYSA-N CCC1=CN=C2C=CC(=CN2C1=O)C(=O)O Chemical compound CCC1=CN=C2C=CC(=CN2C1=O)C(=O)O BRJCJAMOXBYZNP-UHFFFAOYSA-N 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 125000005805 dimethoxy phenyl group Chemical group 0.000 description 2
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- FNENWZWNOPCZGK-UHFFFAOYSA-N ethyl 2-methyl-3-oxobutanoate Chemical compound CCOC(=O)C(C)C(C)=O FNENWZWNOPCZGK-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 125000001207 fluorophenyl group Chemical group 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000004997 halocarbonyl group Chemical group 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- NYJWYCAHJRGKMI-UHFFFAOYSA-N pyrido[1,2-a]pyrimidin-4-one Chemical compound C1=CC=CN2C(=O)C=CN=C21 NYJWYCAHJRGKMI-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZWXZYBAUPOHDSV-UHFFFAOYSA-N 11-oxo-1,8-diazatricyclo[5.4.0.02,4]undeca-5,7,9-triene-4-carboxylic acid Chemical compound C1C2C1(C=CC=1N2C(C=CN=1)=O)C(=O)O ZWXZYBAUPOHDSV-UHFFFAOYSA-N 0.000 description 1
- RHJBBTFTJKNVHO-UHFFFAOYSA-N 11-oxo-9-propyl-1,8-diazatricyclo[5.4.0.02,4]undeca-5,7,9-triene-4-carboxylic acid Chemical compound C(CC)C=1N=C2N(C(C=1)=O)C1C(C=C2)(C(=O)O)C1 RHJBBTFTJKNVHO-UHFFFAOYSA-N 0.000 description 1
- RPHXOQPHBQPBRN-UHFFFAOYSA-N 2,3-dimethyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1=CC(C(O)=O)=CN2C(=O)C(C)=C(C)N=C21 RPHXOQPHBQPBRN-UHFFFAOYSA-N 0.000 description 1
- PNSYENMZJVVQSE-PKNBQFBNSA-N 2-[(E)-2-(2-ethoxyphenyl)ethenyl]-3-ethyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound CCOC1=CC=CC=C1\C=C\C1=C(CC)C(=O)N2C=C(C(O)=O)C=CC2=N1 PNSYENMZJVVQSE-PKNBQFBNSA-N 0.000 description 1
- LSNZSAJMKBSNOH-PKNBQFBNSA-N 2-[(E)-2-(2-methylphenyl)ethenyl]-3-propyl-4H-pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound CC1=C(C=CC=C1)/C=C/C=1N=C2N(CC=1CCC)C=C(C=C2)C(=O)O LSNZSAJMKBSNOH-PKNBQFBNSA-N 0.000 description 1
- UEIGCVITHYNLAK-ACCUITESSA-N 2-[(e)-2-(2,3-diethoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC(OCC)=C1OCC UEIGCVITHYNLAK-ACCUITESSA-N 0.000 description 1
- ZVNGGZZUMWVPKQ-CSKARUKUSA-N 2-[(e)-2-(2,3-dimethoxyphenyl)ethenyl]-3-ethyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CC)=C1\C=C\C1=CC=CC(OC)=C1OC ZVNGGZZUMWVPKQ-CSKARUKUSA-N 0.000 description 1
- SYOPHSJTGALUIF-VQHVLOKHSA-N 2-[(e)-2-(2,3-dimethoxyphenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound COC1=CC=CC(\C=C\C2=C(C(=O)N3C=C(C=CC3=N2)C(O)=O)C)=C1OC SYOPHSJTGALUIF-VQHVLOKHSA-N 0.000 description 1
- JUWAVQMZQGPJCK-PKNBQFBNSA-N 2-[(e)-2-(2,3-dimethoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC(OC)=C1OC JUWAVQMZQGPJCK-PKNBQFBNSA-N 0.000 description 1
- KNKYSNAAAFEGNW-CSKARUKUSA-N 2-[(e)-2-(2,4-dimethylphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=C(C)C=C1C KNKYSNAAAFEGNW-CSKARUKUSA-N 0.000 description 1
- HPZKVBSEEAVINQ-FNORWQNLSA-N 2-[(e)-2-(2,4-dimethylphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound CC1=CC(C)=CC=C1\C=C\C1=CC(=O)N(C=C(C=C2)C(O)=O)C2=N1 HPZKVBSEEAVINQ-FNORWQNLSA-N 0.000 description 1
- FYQDKIHSZVERIG-CSKARUKUSA-N 2-[(e)-2-(2-chlorophenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC=C1Cl FYQDKIHSZVERIG-CSKARUKUSA-N 0.000 description 1
- FAIJTSZHGSQHNL-VQHVLOKHSA-N 2-[(e)-2-(2-methoxyphenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound COC1=CC=CC=C1\C=C\C1=C(C)C(=O)N2C=C(C(O)=O)C=CC2=N1 FAIJTSZHGSQHNL-VQHVLOKHSA-N 0.000 description 1
- DZRRQQLDFRNBQX-SOFGYWHQSA-N 2-[(e)-2-(2-methylphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound CC1=CC=CC=C1\C=C\C1=CC(=O)N(C=C(C=C2)C(O)=O)C2=N1 DZRRQQLDFRNBQX-SOFGYWHQSA-N 0.000 description 1
- BVTBNNWVOOESOL-QPJJXVBHSA-N 2-[(e)-2-(3,4-dimethoxyphenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C1=C(C)C(=O)N2C=C(C(O)=O)C=CC2=N1 BVTBNNWVOOESOL-QPJJXVBHSA-N 0.000 description 1
- MPUWVLLAOPUDJY-FNORWQNLSA-N 2-[(e)-2-(3-chlorophenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(C)=C1\C=C\C1=CC=CC(Cl)=C1 MPUWVLLAOPUDJY-FNORWQNLSA-N 0.000 description 1
- LBZGEWSOAKEIGR-FNORWQNLSA-N 2-[(e)-2-(3-hydroxyphenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(C)=C1\C=C\C1=CC=CC(O)=C1 LBZGEWSOAKEIGR-FNORWQNLSA-N 0.000 description 1
- USGXGNSGTYPKNL-SOFGYWHQSA-N 2-[(e)-2-(3-methoxyphenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound COC1=CC=CC(\C=C\C2=C(C(=O)N3C=C(C=CC3=N2)C(O)=O)C)=C1 USGXGNSGTYPKNL-SOFGYWHQSA-N 0.000 description 1
- IWLWBSZEPVUIQK-XBXARRHUSA-N 2-[(e)-2-(4-hydroxyphenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(C)=C1\C=C\C1=CC=C(O)C=C1 IWLWBSZEPVUIQK-XBXARRHUSA-N 0.000 description 1
- QZGPTLMAZJQITC-YRNVUSSQSA-N 2-[(e)-2-(4-methoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=C(OC)C=C1 QZGPTLMAZJQITC-YRNVUSSQSA-N 0.000 description 1
- WJQTVMXTAYBVKO-PKNBQFBNSA-N 2-[(e)-2-(4-methylphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=C(C)C=C1 WJQTVMXTAYBVKO-PKNBQFBNSA-N 0.000 description 1
- XPMGBTNNNFIPKF-CMDGGOBGSA-N 2-[(e)-2-(5-methylthiophen-2-yl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=C(C)S1 XPMGBTNNNFIPKF-CMDGGOBGSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 229940013085 2-diethylaminoethanol Drugs 0.000 description 1
- MUTCYYLTQDVXDV-UHFFFAOYSA-N 2-ethyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C(C)C=1N=C2N(C(C=1)=O)C=C(C=C2)C(=O)O MUTCYYLTQDVXDV-UHFFFAOYSA-N 0.000 description 1
- 239000001431 2-methylbenzaldehyde Substances 0.000 description 1
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- PRGXNZOHNAHPAZ-PKNBQFBNSA-N 3-butyl-2-[(E)-2-(3-methylphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCCC)=C1\C=C\C1=CC=CC(C)=C1 PRGXNZOHNAHPAZ-PKNBQFBNSA-N 0.000 description 1
- KMHFOKZNBXDVTP-PKNBQFBNSA-N 3-butyl-2-[(e)-2-(3-methoxyphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCCC)=C1\C=C\C1=CC=CC(OC)=C1 KMHFOKZNBXDVTP-PKNBQFBNSA-N 0.000 description 1
- SRWILAKSARHZPR-UHFFFAOYSA-N 3-chlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1 SRWILAKSARHZPR-UHFFFAOYSA-N 0.000 description 1
- ATSOAUIOEMZMPB-VQHVLOKHSA-N 3-ethyl-2-[(E)-2-(3-methylphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CC)=C1\C=C\C1=CC=CC(C)=C1 ATSOAUIOEMZMPB-VQHVLOKHSA-N 0.000 description 1
- QFNXVLKVEJIQSD-CSKARUKUSA-N 3-ethyl-2-[(e)-2-(2-methylphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CC)=C1\C=C\C1=CC=CC=C1C QFNXVLKVEJIQSD-CSKARUKUSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- GYELGGWGTBIBIX-SOFGYWHQSA-N 4-oxo-2-[(e)-2-phenylethenyl]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C=1C(=O)N2C=C(C(=O)O)C=CC2=NC=1\C=C\C1=CC=CC=C1 GYELGGWGTBIBIX-SOFGYWHQSA-N 0.000 description 1
- GHTOWQFLZXQLOA-CMDGGOBGSA-N 4-oxo-3-propyl-2-[(e)-2-pyridin-2-ylethenyl]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC=N1 GHTOWQFLZXQLOA-CMDGGOBGSA-N 0.000 description 1
- VZHYHFJIYRNWJU-MDZDMXLPSA-N 5-[(e)-2-(2-methylphenyl)ethenyl]-7-oxo-6-propyl-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CCC)=C1\C=C\C1=CC=CC=C1C VZHYHFJIYRNWJU-MDZDMXLPSA-N 0.000 description 1
- NNMZQCMESMNNGO-AATRIKPKSA-N 5-[(e)-2-(3-chlorophenyl)ethenyl]-6-methyl-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(C)=C1\C=C\C1=CC=CC(Cl)=C1 NNMZQCMESMNNGO-AATRIKPKSA-N 0.000 description 1
- INLRWAQOIADUGV-QPJJXVBHSA-N 5-[(e)-2-(4-hydroxyphenyl)ethenyl]-6-methyl-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(C)=C1\C=C\C1=CC=C(O)C=C1 INLRWAQOIADUGV-QPJJXVBHSA-N 0.000 description 1
- WTQMMJYVBXGMOK-JXMROGBWSA-N 5-[(e)-2-(4-methoxyphenyl)ethenyl]-7-oxo-6-propyl-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CCC)=C1\C=C\C1=CC=C(OC)C=C1 WTQMMJYVBXGMOK-JXMROGBWSA-N 0.000 description 1
- HGRROMMJOUGGKE-SNAWJCMRSA-N 5-[(e)-2-(furan-2-yl)ethenyl]-6-methyl-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(C)=C1\C=C\C1=CC=CO1 HGRROMMJOUGGKE-SNAWJCMRSA-N 0.000 description 1
- ZCIFWRHIEBXBOY-UHFFFAOYSA-N 6-aminonicotinic acid Chemical compound NC1=CC=C(C(O)=O)C=N1 ZCIFWRHIEBXBOY-UHFFFAOYSA-N 0.000 description 1
- INGRXJPPWZZMHA-RMKNXTFCSA-N 6-ethyl-5-[(e)-2-(4-methoxyphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CC)=C1\C=C\C1=CC=C(OC)C=C1 INGRXJPPWZZMHA-RMKNXTFCSA-N 0.000 description 1
- MUBLGVAZTADGNO-VOTSOKGWSA-N 7-oxo-5-[(e)-2-phenylethenyl]-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound C1=CC2(C(=O)O)CC2N(C(C=2)=O)C1=NC=2\C=C\C1=CC=CC=C1 MUBLGVAZTADGNO-VOTSOKGWSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- SAIKULLUBZKPDA-UHFFFAOYSA-N Bis(2-ethylhexyl) amine Chemical compound CCCCC(CC)CNCC(CC)CCCC SAIKULLUBZKPDA-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- XPUCWTAUJMFPES-UHFFFAOYSA-N CCC1=CN=C2C=CC3(CC3N2C1=O)C(=O)O Chemical compound CCC1=CN=C2C=CC3(CC3N2C1=O)C(=O)O XPUCWTAUJMFPES-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001239379 Calophysus macropterus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- 229910018954 NaNH2 Inorganic materials 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000004479 aerosol dispenser Substances 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000003302 alkenyloxy group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940125708 antidiabetic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001559 cyclopropyl group Chemical class [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- UMNKXPULIDJLSU-UHFFFAOYSA-N dichlorofluoromethane Chemical compound FC(Cl)Cl UMNKXPULIDJLSU-UHFFFAOYSA-N 0.000 description 1
- 229940099364 dichlorofluoromethane Drugs 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- DKWOHBPRFZIUQL-UHFFFAOYSA-N dimethyl-methylidene-oxo-$l^{6}-sulfane Chemical compound C[S+](C)([CH2-])=O DKWOHBPRFZIUQL-UHFFFAOYSA-N 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical class CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- ZTOQBHVLCJERBS-UHFFFAOYSA-N ethyl 2-acetylhexanoate Chemical compound CCCCC(C(C)=O)C(=O)OCC ZTOQBHVLCJERBS-UHFFFAOYSA-N 0.000 description 1
- VHOACUZAQKMOEQ-UHFFFAOYSA-N ethyl 2-acetylpentanoate Chemical compound CCCC(C(C)=O)C(=O)OCC VHOACUZAQKMOEQ-UHFFFAOYSA-N 0.000 description 1
- OKANYBNORCUPKZ-UHFFFAOYSA-N ethyl 2-ethyl-3-oxobutanoate Chemical compound CCOC(=O)C(CC)C(C)=O OKANYBNORCUPKZ-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 229940093858 ethyl acetoacetate Drugs 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052740 iodine Chemical group 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- LRPCLTPZMUIPFK-UHFFFAOYSA-N methane;sulfuric acid Chemical compound C.OS(O)(=O)=O LRPCLTPZMUIPFK-UHFFFAOYSA-N 0.000 description 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
- BRXVNCLGKGIVTJ-VAWYXSNFSA-N methyl 10-butyl-11-oxo-9-[(E)-2-phenylethenyl]-1,8-diazatricyclo[5.4.0.02,4]undeca-5,7,9-triene-4-carboxylate Chemical compound COC(=O)C12C=CC=3N(C(C(=C(N=3)\C=C\C3=CC=CC=C3)CCCC)=O)C1C2 BRXVNCLGKGIVTJ-VAWYXSNFSA-N 0.000 description 1
- JACPDLJUQLKABC-UHFFFAOYSA-N methyl 6-aminopyridine-3-carboxylate Chemical compound COC(=O)C1=CC=C(N)N=C1 JACPDLJUQLKABC-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- BTFQKIATRPGRBS-UHFFFAOYSA-N o-tolualdehyde Chemical compound CC1=CC=CC=C1C=O BTFQKIATRPGRBS-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000021962 pH elevation Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- BWESROVQGZSBRX-UHFFFAOYSA-N pyrido[3,2-d]pyrimidine Chemical compound C1=NC=NC2=CC=CN=C21 BWESROVQGZSBRX-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- QPILZZVXGUNELN-UHFFFAOYSA-M sodium;4-amino-5-hydroxynaphthalene-2,7-disulfonate;hydron Chemical compound [Na+].OS(=O)(=O)C1=CC(O)=C2C(N)=CC(S([O-])(=O)=O)=CC2=C1 QPILZZVXGUNELN-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7915810 | 1979-05-08 | ||
| GB7915810 | 1979-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU82419A1 true LU82419A1 (fr) | 1980-07-31 |
Family
ID=10504995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU82419A LU82419A1 (fr) | 1979-05-08 | 1980-05-05 | Pyrido(1,2-a)pyrimidines substituees |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US4310526A (cs) |
| JP (1) | JPS562983A (cs) |
| AT (1) | AT375370B (cs) |
| AU (1) | AU527931B2 (cs) |
| BE (1) | BE883150A (cs) |
| CA (1) | CA1134359A (cs) |
| CH (1) | CH647777A5 (cs) |
| CS (2) | CS528780A2 (cs) |
| DE (1) | DE3015738A1 (cs) |
| DK (1) | DK200280A (cs) |
| ES (1) | ES8104287A1 (cs) |
| FI (1) | FI68824C (cs) |
| FR (1) | FR2456093A1 (cs) |
| GB (1) | GB2050353B (cs) |
| GR (1) | GR68075B (cs) |
| HU (1) | HU181778B (cs) |
| IE (1) | IE49787B1 (cs) |
| IL (1) | IL59802A (cs) |
| IT (1) | IT1209326B (cs) |
| LU (1) | LU82419A1 (cs) |
| NL (1) | NL8002656A (cs) |
| NO (1) | NO153137C (cs) |
| NZ (1) | NZ193579A (cs) |
| PH (1) | PH16695A (cs) |
| PT (1) | PT71197A (cs) |
| SE (1) | SE437158B (cs) |
| SU (2) | SU1217259A3 (cs) |
| ZA (1) | ZA802390B (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT377586B (de) | 1981-06-30 | 1985-04-10 | Erba Farmitalia | Verfahren zur herstellung von substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)chinazolinen |
| US4537962A (en) * | 1982-02-04 | 1985-08-27 | Farmitalia Carlo Erba, S.P.A. | Substituted 1,3,4-thiadiazolo[3,2-A]pyrimidines and compositions containing them |
| CA1211111A (en) * | 1982-02-15 | 1986-09-09 | Isao Yanagisawa | Process for preparing novel pyrimidone compounds |
| ES521739A0 (es) * | 1982-04-29 | 1984-07-01 | Erba Farmitalia | Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas. |
| IL69274A (en) * | 1982-08-05 | 1986-08-31 | Erba Farmitalia | (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them |
| GB8300728D0 (en) * | 1983-01-12 | 1983-02-16 | Erba Farmitalia | Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives |
| US4457932A (en) * | 1983-07-22 | 1984-07-03 | Bristol-Myers Company | Anti-ulcer agents |
| GB8501015D0 (en) * | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
| JP2668259B2 (ja) * | 1988-02-18 | 1997-10-27 | 塩野義製薬株式会社 | 複素環化合物および抗潰瘍剤 |
| CA2724008A1 (en) * | 2008-01-11 | 2009-09-11 | Prasada Rao V.S. Lingam | Fused pyrimidine derivatives as trpv3 modulators |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209622A (en) * | 1973-03-30 | 1980-06-24 | Chinoin Gygyszer es Vegyeszeti Termekek Gyara Rt. | 3-(Ethoxycarbonyl-methyl)-6-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine |
| US3935197A (en) * | 1975-05-16 | 1976-01-27 | E. R. Squibb & Sons, Inc. | 2-Styryl-4H-pyrido(1,2-a)pyrimidin-4-ones |
| HU178910B (en) | 1977-08-19 | 1982-07-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 2,3-disubstituted-4-oxo-4h-pyrido/1,2-a/-pyrimidines |
| HU184058B (en) | 1977-12-29 | 1984-06-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing new compounds with nitrogen bridge head |
| HU180701B (en) | 1977-12-29 | 1983-04-29 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing pyrido-/1,2-a/pyrimidines containing a carboxylic or ester group on the pirimidimering |
-
1980
- 1980-04-10 IL IL59802A patent/IL59802A/xx unknown
- 1980-04-10 US US06/138,879 patent/US4310526A/en not_active Expired - Lifetime
- 1980-04-10 AU AU57319/80A patent/AU527931B2/en not_active Ceased
- 1980-04-17 GB GB8012638A patent/GB2050353B/en not_active Expired
- 1980-04-18 PH PH23918A patent/PH16695A/en unknown
- 1980-04-21 ZA ZA00802390A patent/ZA802390B/xx unknown
- 1980-04-23 GR GR61754A patent/GR68075B/el unknown
- 1980-04-24 DE DE19803015738 patent/DE3015738A1/de not_active Withdrawn
- 1980-04-30 NZ NZ193579A patent/NZ193579A/xx unknown
- 1980-05-05 LU LU82419A patent/LU82419A1/fr unknown
- 1980-05-06 IT IT8021821A patent/IT1209326B/it active
- 1980-05-06 FI FI801464A patent/FI68824C/fi not_active IP Right Cessation
- 1980-05-07 SE SE8003433A patent/SE437158B/sv not_active IP Right Cessation
- 1980-05-07 CH CH3571/80A patent/CH647777A5/de not_active IP Right Cessation
- 1980-05-07 ES ES491238A patent/ES8104287A1/es not_active Expired
- 1980-05-07 SU SU802917352A patent/SU1217259A3/ru active
- 1980-05-07 IE IE945/80A patent/IE49787B1/en unknown
- 1980-05-07 DK DK200280A patent/DK200280A/da not_active Application Discontinuation
- 1980-05-07 BE BE2/500A patent/BE883150A/fr not_active IP Right Cessation
- 1980-05-07 NO NO801342A patent/NO153137C/no unknown
- 1980-05-07 CS CS805287A patent/CS528780A2/cs unknown
- 1980-05-07 CA CA000351417A patent/CA1134359A/en not_active Expired
- 1980-05-07 PT PT71197A patent/PT71197A/pt unknown
- 1980-05-07 HU HU801121A patent/HU181778B/hu unknown
- 1980-05-07 CS CS803213A patent/CS244107B2/cs unknown
- 1980-05-08 AT AT0245680A patent/AT375370B/de not_active IP Right Cessation
- 1980-05-08 JP JP6001780A patent/JPS562983A/ja active Pending
- 1980-05-08 FR FR8010290A patent/FR2456093A1/fr active Granted
- 1980-05-08 NL NL8002656A patent/NL8002656A/nl not_active Application Discontinuation
-
1981
- 1981-05-27 US US06/267,450 patent/US4341780A/en not_active Expired - Fee Related
- 1981-06-24 SU SU813308438A patent/SU1158045A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0091241B1 (en) | Condensed pyrrolinone derivatives, and their production | |
| KR100191774B1 (ko) | 피라졸로[1,5-알파] 피리미딘 유도체 및 이것을 함유하는 항염증제 | |
| KR101126383B1 (ko) | 3환계 화합물 | |
| US5270316A (en) | Condensed purine derivatives | |
| DE69524114T2 (de) | Naphthyridinonderivate | |
| EP1891067B1 (en) | Androgen receptor modulator compounds and methods | |
| JPH05345771A (ja) | サッカリン誘導体タンパク質分解酵素阻害剤 | |
| CA2104883A1 (fr) | Derives d'acide thienyl ou pyrrolyl carboxyliques, leur preparation et medicaments les contenant | |
| BG60337B2 (bg) | 4-амино-2-(4-)1,4-бензодиоксан-2-карбонил(пиперазин-1-ил или хомопиперазин-1-ил)хиназолини с антихипертензивно действие | |
| JPS61176591A (ja) | 新規チエノ‐トリアゾロ‐１，４‐ジアゼピノ‐２‐カルボン酸アミド | |
| FR2523582A1 (fr) | Nouvelles 1h-pyrazolo(1,5-a)pyrimidines substituees, utiles notamment comme medicaments anti-inflammatoires et analgesiques, et procede pour leur preparation | |
| AU611610B2 (en) | Pyridazinone derivatives | |
| EP0379412B1 (fr) | Dérivés de benzonaphtyridine-1,8 leur préparation et les compositions qui les contiennent | |
| LU82419A1 (fr) | Pyrido(1,2-a)pyrimidines substituees | |
| EP0591046B1 (fr) | Dérivés chromeniques à chaíne triénique, utilisables dans le traitement de l'ostéoporose et des affections inflammatoires | |
| HU190377B (en) | Process for preparing theophyllinyl-alkyl-oxadiazoles | |
| WO1985004172A1 (en) | Polyazaheterocyclic derivatives, process for their preparation, and pharmaceutical composition | |
| US3379729A (en) | Piperazinyldibenzothiepins | |
| JPH01151570A (ja) | クロマン誘導体、その製造法、及びその医薬での使用 | |
| FR2510113A1 (cs) | ||
| EP0316790B1 (en) | Rhodanine derivatives, a process for their preparation, pharmaceutical compositions and their use | |
| EP0402232A1 (fr) | Dérivés de pyridobenzoindole, leur préparation et les compositions qui les contiennent | |
| EP0233800B1 (fr) | Dérivés d'imidazo[1,2-a]quinoléines, leur préparation et leur application en thérapeutique | |
| JPS6399057A (ja) | グリシン誘導体 | |
| US4843080A (en) | 1,12-disubstituted octahydroindolo[2,3-]quinolizine derivatives, pharmaceutical compositions |